Chemoinformaics analysis of 4-(2-NITROETHYL)PHENOL-O-PRIMEVEROSIDE
| Molecular Weight | 461.42 | nRot | 8 |
| Heavy Atom Molecular Weight | 434.204 | nRig | 19 |
| Exact Molecular Weight | 461.153 | nRing | 3 |
| Solubility: LogS | -1.218 | nHRing | 2 |
| Solubility: LogP | -1.799 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 1 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 6 |
| nHA | 12 | APOL | 60.4574 |
| nHD | 6 | BPOL | 35.1966 |
| QED | 0.171 |
| Synth | 4.43 |
| Natural Product Likeliness | 1.494 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.864 |
| HIA | 0.975 |
| CACO-2 | -5.689 |
| MDCK | 0.000232178 |
| BBB | 0.432 |
| PPB | 0.307585 |
| VDSS | 0.42 |
| FU | 0.39475 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.022 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.172 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.402 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.197 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.01 |
| CL | 1.265 |
| T12 | 0.305 |
| hERG | 0.377 |
| Ames | 0.239 |
| ROA | 0.313 |
| SkinSen | 0.037 |
| Carcinogencity | 0.637 |
| EI | 0.009 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.136 |
| Antiviral | Yes |
| Prediction | 0.635363 |